Flat pricing across all doses (including the new 7.2 mg dose) Mounjaro (tirzepatide) from 299/month Mandatory at-home blood test before prescribing
Discontinuation rates due to adverse events were 2.2%, 4.5%, and 5.1% with retatrutide, respectively, compared with 0.0% with placebo
It is essential that the technology that enables the oral availability of peptide-based drugs was successfully developed
Patients who have a family history of medullary thyroid carcinoma, a very rare form of thyroid cancer, should also not take GLP-1 medications
The Heart Disease Study of Semaglutide in Patients with Type 2 Diabetes (SOUL) is a more extensive and extended phase 3 CVOT presently being conducted, and results are expected in 2024 [55]
AlphaFold has appended projects and research directions